Kiran Mazumdar-Shaw

Founder, Chair And Managing Director,, Biocon
$3.39B
as of 10/04/24

About Kiran Mazumdar-Shaw

Kiran Mazumdar-Shaw, one of India's richest self-made women, founded biopharmaceutical firm Biocon, in 1978. The firm has successfully forayed into the lucrative U.S. market.

The company has Asia's largest insulin factory in Malaysia's Johor region.

Biocon Biologics acquired the biosimilars business of Viatris in 2022 for $3.3 billion.

In 2022, the Central Bureau of Investigation arrested a Biocon Biologics executive and four others in an alleged bribery case. The company denied any wrongdoing.

Biocon-backed cancer therapy company Bicara Therapeutics raised $362 million in an IPO on the Nasdaq in September 2024.

Personal stats

Citizenship

India

Source of wealth

Biopharmaceuticals

Residence

Bangalore, India

Marital status

Widowed

Birth date

03/23/53 (age 71)

Education

Bachelor of Arts/Science, Bangalore University; Master of Science, Melbourne University

Self-made

self-made

Kiran Mazumdar-Shaw’s fortune is worth

56K

troy ounces of gold

52K

median U.S. household

34K

median U.S. income

0.068%

U.S. credit card volume

0.014%

GDP of the United States

0.01%

United States debt

Net worth history

Annual ranking

Did you know?

Her philanthropic initiative, Mazumdar Shaw Medical Center, aims to create a sustainable, affordable cancer care model.

Net worth over time

Real-time ranking

Financial assets

NASDAQ | BCAX-US

Bicara Therapeutics

BSE INDIA | 532523-IN

Biocon

BSE INDIA | 539551-IN

Narayana Hrudayalaya

Images © Forbes.com. All rights reserved.